CollPlant Biotechnologies Ltd financial data

Symbol
CLGN on Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
4 Oppenheimer St., 11 Th Floor, Rehovot, Israel
State of incorporation
Israel
Fiscal year end
December 31
Former names
CollPlant Holdings Ltd. (to 6/6/2019)
Latest financial report
20-F - Q4 2024 - Mar 26, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.5M shares +0.02%
Common Stock, Shares, Outstanding 11.5M shares +0.02%
Common Stock, Value, Issued 4.98M USD +0.02%
Weighted Average Number of Shares Outstanding, Basic 11.5M shares +0.75%
Weighted Average Number of Shares Outstanding, Diluted 11.5M shares -2.74%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 249K USD -97.6%
Cost of Revenue 536K USD -12.8%
Research and Development Expense 2.7M USD +4.78%
General and Administrative Expense 1.42M USD +7.89%
Operating Income (Loss) -4.41M USD -178%
Nonoperating Income (Expense) 196K USD +131%
Net Income (Loss) Attributable to Parent -4.21M USD -173%
Earnings Per Share, Basic -0.37 USD/shares -173%
Earnings Per Share, Diluted -0.37 USD/shares -176%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11.9M USD -55.4%
Accounts Receivable, after Allowance for Credit Loss, Current 150K USD
Inventory, Net 440K USD -38.4%
Assets, Current 13.2M USD -53%
Property, Plant and Equipment, Net 2.29M USD -17.9%
Operating Lease, Right-of-Use Asset 2.99M USD -2.57%
Intangible Assets, Net (Excluding Goodwill) 131K USD -30.3%
Assets 18.7M USD -45.2%
Liabilities, Current 2.97M USD -8.64%
Operating Lease, Liability, Noncurrent 2.28M USD -10.3%
Liabilities 5.25M USD -9.35%
Accumulated Other Comprehensive Income (Loss), Net of Tax -969K USD 0%
Retained Earnings (Accumulated Deficit) -113M USD -17.2%
Stockholders' Equity Attributable to Parent 13.5M USD -52.5%
Liabilities and Equity 18.7M USD -45.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 30M shares 0%
Common Stock, Shares, Issued 11.5M shares +0.02%
Common Stock, Par or Stated Value Per Share 1.5 ILS/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.9M USD -55.4%
Deferred Tax Assets, Valuation Allowance 22.8M USD +18.2%
Deferred Tax Assets, Gross 23.5M USD +17.4%
Operating Lease, Liability 3.08M USD -2.47%
Lessee, Operating Lease, Liability, to be Paid 3.62M USD -5.21%
Property, Plant and Equipment, Gross 9.31M USD +5.42%
Operating Lease, Liability, Current 806K USD +29.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 831K USD +8.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 926K USD +12.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 542K USD -18.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 776K USD +16.9%
Deferred Tax Assets, Operating Loss Carryforwards 18.7M USD +20.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 765K USD +20.3%
Additional Paid in Capital 120M USD
Share-based Payment Arrangement, Expense 490K USD +45%